Minimum Residual Disease in Acute Lymphoblastic Leukemia

5 Visninger
administrator
administrator
08/04/23

In this segment, Jeffrey Lancet, MD; Raoul Tibes, MD; and Mark R. Litzow, MD, describe various methodologies in monitoring minimum residual disease in acute lymphoblastic leukemia.

  • Kategori

Vis mere

0 Kommentarer Sorter efter

Ingen kommentarer fundet

Facebook kommentarer

Næste